Entering text into the input field will update the search result below

Shire to present research on recently approved ADHD med Mydayis at upcoming Psych Congress; shares up 2% premarket

Sep. 15, 2017 7:31 AM ETShire PLC (SHPG) StockBy: Douglas W. House, SA News Editor1 Comment
  • Shire plc (NASDAQ:SHPG) is up 2% premarket on light volume on the heels of its announcement of three poster presentations on ADHD med MYDAYIS (mixed salts of a single-entity amphetamine product) at Psych Congress in New Orleans on Sunday, September 17.
  • The FDA approved once-daily MYDAYIS in June.

Recommended For You

Related Stocks

SymbolLast Price% Chg
SHPG--
Shire PLC